Clinical Trials Logo

Clinical Trial Summary

This study explores the influence of the food matrix of seaweed-containing food products on iodine bioavailability. The investigation will ascertain whether iodine bioavailability (as a percentage of the dose ingested that is excreted in urine) is comparable between seaweed sheets, seaweed powder (in capsules), pizza fortified with powdered seaweed, and potassium iodide supplements.

Clinical Trial Description

Iodine deficiency can have serious consequences, especially during pregnancy and lactation where the fetus is entirely dependent on its mother for the provision of iodine. There is no current iodine fortification programme in the United Kingdom, and the main sources of iodine are from dietary sources, such as dairy products and seafood. However, seaweed is also a rich source of iodine; the inclusion of iodine (via powdered seaweed) in commonly consumed foods is of potential benefit as a strategy, as it removes the need for consumers to alter their dietary behaviours, which are often culturally standardized. Seaweed intake (via supplements) can increase the iodine status of women with habitually low-iodine diets. However, reduced bioavailability of iodine from the seaweed matrix has also been displayed, which could impact iodine intake should individuals choose to use seaweed as a dietary source of iodine. This study tests the influence of the food matrix of seaweed-containing products on iodine bioavailability. This will be evaluated over the course of 27 days, in a randomized crossover trial design with 4 arms. Each arm will be separated by 7 washout days, and participants will follow a low iodine diet (avoiding all seafood, seaweed products, eggs, dairy, fortified plant milk and goitrogens (cabbage, soy etc.) for the 2 days preceding and the 1 day following each feed. 1. Food arm: portion equivalent to 200µg of iodine, half a pizza (Eat Balanced pizza) (consumed with ~450mL of water) 2. Seaweed sheet arm: portion equivalent to 200µg of iodine, ~10g of seaweed sheets (consumed alongside 2 slices of white bread and ~450mL of water) 3. Seaweed powder arm: portion equivalent to 200µg of iodine, 1 capsule (consumed alongside 2 slices of white bread and ~450mL of water). 4. Potassium iodide supplement arm: portion equivalent to 200µg of iodine with ~450mL of water (Piping Rock Potassium Iodide Supplement, consumed alongside 2 slices of white bread) Iodine excretion will be monitored in urine collected during the 12 hours preceding and 36 hours following the meal. Urine will be collected in 8 timed fractions (0-1h, 1-2h, 2-3h, 3-5h, 5-8h, 8-12h, 12-24h, 24-36h) and participants will be provided with containers and instructions on how to collect their urine. A single fecal sample will also be collected before the first feed, and within 24 hours of all feeds. Participants will also keep a detailed food diary on all study days to enable iodine ingestion monitoring. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT04867291
Study type Interventional
Source University of Glasgow
Contact Martha L Redway, BSc
Phone 07510924724
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date April 2021
Completion date November 2021

See also
  Status Clinical Trial Phase
Completed NCT03590431 - Bioavailability of Iodine in Cow's Milk in Swiss Adults N/A
Completed NCT04867031 - Impact of the Food Matrix on Iodine Bioavailability N/A